us > Maine > Oxford > Gilead > Latest & Local News
Gilead news
Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC - Yahoo Finance
Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC
Yahoo Finance
📢 Published on 📅 June 13, 2026 🕒 19:13
Victory Capital Management Inc. Sells 109,808 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Victory Capital Management Inc. Sells 109,808 Shares of Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 13, 2026 🕒 11:46
Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp
MarketBeat
📢 Published on 📅 June 13, 2026 🕒 11:18
Gilead (GILD) Supports Faster South Africa Access to Lenacapavir - Insider Monkey
Gilead (GILD) Supports Faster South Africa Access to Lenacapavir
Insider Monkey
📢 Published on 📅 June 13, 2026 🕒 10:46
Rhenman & Partners Asset Management AB Buys 46,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Rhenman & Partners Asset Management AB Buys 46,000 Shares of Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 13, 2026 🕒 10:40
Trillium Asset Management LLC Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Trillium Asset Management LLC Decreases Stock Position in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 13, 2026 🕒 09:41
Macquarie Group Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Macquarie Group Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 13, 2026 🕒 09:41
Castleark Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Castleark Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 13, 2026 🕒 07:35
'Remembrance work is future work': Gilead commits $3M for HIV/AIDS education and preservation - Local News Matters
'Remembrance work is future work': Gilead commits $3M for HIV/AIDS education and preservation
Local News Matters
📢 Published on 📅 June 13, 2026 🕒 00:00
‘Nothing gets by her’: ‘The Testaments’ star Ann Dowd on how Aunt Lydia survives in Gilead - Gold Derby
‘Nothing gets by her’: ‘The Testaments’ star Ann Dowd on how Aunt Lydia survives in Gilead
Gold Derby
📢 Published on 📅 June 12, 2026 🕒 23:25
National AIDS Memorial And Gilead Foundation: About $3 Million Commitment Launched To Expand HIV/AIDS Education And Community Leadership - Pulse 2.0
Pulse 2.0
📢 Published on 📅 June 12, 2026 🕒 15:12
Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief - Business Wire
Business Wire
📢 Published on 📅 June 12, 2026 🕒 12:30
UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 12, 2026 🕒 12:02
Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 12, 2026 🕒 12:02
Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS
MarketBeat
📢 Published on 📅 June 12, 2026 🕒 11:14
Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 12, 2026 🕒 09:27
Friday Five – Weighing the competition at ADA, Miel's first big deal at GSK, Gilead & Merck's manic Monday…and more - FirstWord Pharma
FirstWord Pharma
📢 Published on 📅 June 12, 2026 🕒 02:16
How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones - simplywall.st
How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones
simplywall.st
📢 Published on 📅 June 11, 2026 🕒 22:43
Gilead Sciences Inc (GILD) Stock Up 3.6% but GF Value Says Overv - GuruFocus
Gilead Sciences Inc (GILD) Stock Up 3.6% but GF Value Says Overv
GuruFocus
📢 Published on 📅 June 11, 2026 🕒 22:16
National AIDS Memorial and the Gilead Foundation Launch Major Investment to Expand HIV/AIDS Education and Community Leadership - Gilead Sciences
Gilead Sciences
📢 Published on 📅 June 11, 2026 🕒 20:31
Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now? - Yahoo Finance
Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now?
Yahoo Finance
📢 Published on 📅 June 11, 2026 🕒 19:55
African American church has had its last service in its historic Fort Worth building - Fort Worth Star-Telegram
African American church has had its last service in its historic Fort Worth building
Fort Worth Star-Telegram
📢 Published on 📅 June 11, 2026 🕒 18:51
Chase Infiniti on Hiding ‘One Battle After Another’ Role From ‘The Testaments’ Co-Stars and Becoming Elisabeth Moss’ Daughter for Gilead’s Teen-Girl Wasteland - Variety
Variety
📢 Published on 📅 June 11, 2026 🕒 17:54
Gilead Sciences Inc Stock (GILD) Moved Up by 3.48% on Jun 11: Key Drivers Unveiled - TradingKey
Gilead Sciences Inc Stock (GILD) Moved Up by 3.48% on Jun 11: Key Drivers Unveiled
TradingKey
📢 Published on 📅 June 11, 2026 🕒 16:15
Man killed in motorcycle crash on I-77 in Huntersville - WBTV
Man killed in motorcycle crash on I-77 in Huntersville
WBTV
📢 Published on 📅 June 11, 2026 🕒 13:14
Motorcyclist dies after colliding with Tesla in toll lane on I-77 South in Huntersville - WCNC
Motorcyclist dies after colliding with Tesla in toll lane on I-77 South in Huntersville
WCNC
📢 Published on 📅 June 11, 2026 🕒 12:43
Scotiabank Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $177 - Moomoo
Scotiabank Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $177
Moomoo
📢 Published on 📅 June 11, 2026 🕒 12:31
Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline Development - Yahoo Finance
Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline Development
Yahoo Finance
📢 Published on 📅 June 11, 2026 🕒 01:00
Gilead Sciences Inc Stock (GILD) Closed Down by 3.12% on Jun 10: What Investors Need To Know - TradingKey
Gilead Sciences Inc Stock (GILD) Closed Down by 3.12% on Jun 10: What Investors Need To Know
TradingKey
📢 Published on 📅 June 10, 2026 🕒 20:14
Motley Fool Asset Management LLC Buys 29,394 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Motley Fool Asset Management LLC Buys 29,394 Shares of Gilead Sciences, Inc. $GILD
MarketBeat
📢 Published on 📅 June 10, 2026 🕒 10:38
Gilead Sciences, Inc. $GILD Shares Sold by BLI Banque de Luxembourg Investments - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by BLI Banque de Luxembourg Investments
MarketBeat
📢 Published on 📅 June 10, 2026 🕒 08:10
Obituary information for Patrick P. Tobin - Snyder Funeral Homes
Obituary information for Patrick P. Tobin
Snyder Funeral Homes
📢 Published on 📅 June 10, 2026 🕒 07:00
Mt. Gilead- Improve Water Assn./ Boil Water Alert - Mississippi State Health Department (.gov)
Mt. Gilead- Improve Water Assn./ Boil Water Alert
Mississippi State Health Department (.gov)
📢 Published on 📅 June 10, 2026 🕒 01:55
Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study - Zacks Investment Research
Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study
Zacks Investment Research
📢 Published on 📅 June 9, 2026 🕒 19:00
Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial - Gilead Sciences (NASDAQ:GILD), Merck & Co (NYS - Benzinga
Benzinga
📢 Published on 📅 June 9, 2026 🕒 17:44
Gilead Balances Trodelvy Setback With Once Weekly HIV Progress - simplywall.st
Gilead Balances Trodelvy Setback With Once Weekly HIV Progress
simplywall.st
📢 Published on 📅 June 9, 2026 🕒 17:29
Gilead’s Mixed Trial News Puts HIV Progress And Oncology Risks In Focus - Yahoo Finance
Gilead’s Mixed Trial News Puts HIV Progress And Oncology Risks In Focus
Yahoo Finance
📢 Published on 📅 June 9, 2026 🕒 17:09
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies - BioPharma Dive
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
BioPharma Dive
📢 Published on 📅 June 9, 2026 🕒 16:28
Merck, Gilead score in effort to develop the first weekly HIV pill - Fierce Pharma
Merck, Gilead score in effort to develop the first weekly HIV pill
Fierce Pharma
📢 Published on 📅 June 9, 2026 🕒 15:20
As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AZ and Daiichi rivals - Fierce Pharma
Fierce Pharma
📢 Published on 📅 June 9, 2026 🕒 15:14
Gilead and Merck’s latest trial success and flop - statnews.com
Gilead and Merck’s latest trial success and flop
statnews.com
📢 Published on 📅 June 9, 2026 🕒 15:12
Trodelvy misses again in lung cancer, but Gilead and Merck have an HIV success to soften the blow - Endpoints News
Trodelvy misses again in lung cancer, but Gilead and Merck have an HIV success to soften the blow
Endpoints News
📢 Published on 📅 June 9, 2026 🕒 14:33
Gilead and MSD’s once-weekly HIV pill meets primary endpoints in Phase III trials - Clinical Trials Arena
Gilead and MSD’s once-weekly HIV pill meets primary endpoints in Phase III trials
Clinical Trials Arena
📢 Published on 📅 June 9, 2026 🕒 14:25
Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble - BioSpace
Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble
BioSpace
📢 Published on 📅 June 9, 2026 🕒 13:16
Merck and Gilead discontinue Phase III KEYNOTE-D46/EVOKE-03 study - The Pharma Letter
Merck and Gilead discontinue Phase III KEYNOTE-D46/EVOKE-03 study
The Pharma Letter
📢 Published on 📅 June 9, 2026 🕒 11:08
Gilead-MSD once-weekly oral HIV regimen meets Phase III endpoints - European Pharmaceutical Review
Gilead-MSD once-weekly oral HIV regimen meets Phase III endpoints
European Pharmaceutical Review
📢 Published on 📅 June 9, 2026 🕒 07:00
Gilead's lung cancer bid for Trodelvy hits wall, but HIV studies deliver better news - FirstWord Pharma
Gilead's lung cancer bid for Trodelvy hits wall, but HIV studies deliver better news
FirstWord Pharma
📢 Published on 📅 June 8, 2026 🕒 23:38
[Press release] Gilead and Merck announce positive topline results from two Phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly HIV treatment - European AIDS Treatment Group
European AIDS Treatment Group
📢 Published on 📅 June 8, 2026 🕒 23:28
Merck, Gilead share positive phase 3 results from combination HIV pill - Seeking Alpha
Merck, Gilead share positive phase 3 results from combination HIV pill
Seeking Alpha
📢 Published on 📅 June 8, 2026 🕒 21:44
Gilead and Merck’s Once-Weekly HIV Combo Pill Works in Trials - Bloomberg.com
Gilead and Merck’s Once-Weekly HIV Combo Pill Works in Trials
Bloomberg.com
📢 Published on 📅 June 8, 2026 🕒 21:19
Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment - Business Wire
Business Wire
📢 Published on 📅 June 8, 2026 🕒 20:35
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study - Business Wire
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
Business Wire
📢 Published on 📅 June 8, 2026 🕒 20:30
Assessing Gilead Sciences (GILD) Valuation As Livdelzi Phase 3 PBC Results Shape Growth Expectations - simplywall.st
Assessing Gilead Sciences (GILD) Valuation As Livdelzi Phase 3 PBC Results Shape Growth Expectations
simplywall.st
📢 Published on 📅 June 8, 2026 🕒 14:27
Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now? - Yahoo Finance
Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?
Yahoo Finance
📢 Published on 📅 June 7, 2026 🕒 20:11
Obituary information for Stoney Grant Hall - Snyder Funeral Homes
Obituary information for Stoney Grant Hall
Snyder Funeral Homes
📢 Published on 📅 June 6, 2026 🕒 16:46
Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa - Yahoo Finance
Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa
Yahoo Finance
📢 Published on 📅 June 5, 2026 🕒 07:00
Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa - Business Wire
Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa
Business Wire
📢 Published on 📅 June 5, 2026 🕒 07:00
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline - Yahoo Finance
Yahoo Finance
📢 Published on 📅 June 4, 2026 🕒 20:15
Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population - Fierce Pharma
Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population
Fierce Pharma
📢 Published on 📅 June 2, 2026 🕒 07:00
ASCO26: Tubulis shares updated ovarian cancer data for ADC behind Gilead takeout - FirstWord Pharma
ASCO26: Tubulis shares updated ovarian cancer data for ADC behind Gilead takeout
FirstWord Pharma
📢 Published on 📅 May 30, 2026 🕒 07:00
ASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’ - Fierce Biotech
ASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’
Fierce Biotech
📢 Published on 📅 May 30, 2026 🕒 07:00
Gilead scraps lead arthritis drug from $405M MiroBio buyout in latest blow to BTLA agonist field - Fierce Biotech
Gilead scraps lead arthritis drug from $405M MiroBio buyout in latest blow to BTLA agonist field
Fierce Biotech
📢 Published on 📅 May 29, 2026 🕒 07:00
The Testaments Costume Designer On Dressing Gilead’s Women - Forbes
The Testaments Costume Designer On Dressing Gilead’s Women
Forbes
📢 Published on 📅 May 27, 2026 🕒 07:00
Gilead's drug wins first-ever US approval for deadly liver infection - Reuters
Gilead's drug wins first-ever US approval for deadly liver infection
Reuters
📢 Published on 📅 May 26, 2026 🕒 07:00
From Gilead to Ladyland: how the rebellious women of literature offer hope in dark times - The Guardian
From Gilead to Ladyland: how the rebellious women of literature offer hope in dark times
The Guardian
📢 Published on 📅 May 24, 2026 🕒 07:00
Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains - Yahoo Finance
Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains
Yahoo Finance
📢 Published on 📅 May 23, 2026 🕒 07:00
Gilead inks $140M API supply deal, tightening ties to Korean manufacturer - BioSpace
Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
BioSpace
📢 Published on 📅 May 22, 2026 🕒 07:00
in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors - Business Wire
Business Wire
📢 Published on 📅 May 22, 2026 🕒 07:00
WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination - World Health Organization (WHO)
WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination
World Health Organization (WHO)
📢 Published on 📅 May 21, 2026 🕒 07:00
Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio - Business Wire
Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio
Business Wire
📢 Published on 📅 May 21, 2026 🕒 07:00
Use of Gilead's HIV prevention shot rises, but US insurance gaps remain - Reuters
Use of Gilead's HIV prevention shot rises, but US insurance gaps remain
Reuters
📢 Published on 📅 May 13, 2026 🕒 07:00
Gilead Sciences Expects Loss This Year on Acquired R&D Expenses - WSJ
Gilead Sciences Expects Loss This Year on Acquired R&D Expenses
WSJ
📢 Published on 📅 May 7, 2026 🕒 07:00
Gilead won’t sell MSF its HIV drug. Its shareholders should ask why - Doctors Without Borders
Gilead won’t sell MSF its HIV drug. Its shareholders should ask why
Doctors Without Borders
📢 Published on 📅 April 30, 2026 🕒 14:06
Is It Time To Revisit Gilead Sciences (GILD) After Recent Share Price Pullback - Yahoo Finance
Is It Time To Revisit Gilead Sciences (GILD) After Recent Share Price Pullback
Yahoo Finance
📢 Published on 📅 April 30, 2026 🕒 07:00
Dean's Speaker Series: Gilead CEO Daniel O’Day on why diverse perspectives drive progress - University of California, Berkeley
Dean's Speaker Series: Gilead CEO Daniel O’Day on why diverse perspectives drive progress
University of California, Berkeley
📢 Published on 📅 April 24, 2026 🕒 07:00
Transforming What’s Next, Now: Gilead’s 2025 Responsible Business and Impact Report - Gilead Sciences
Transforming What’s Next, Now: Gilead’s 2025 Responsible Business and Impact Report
Gilead Sciences
📢 Published on 📅 April 23, 2026 🕒 07:00
Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure - Fierce Biotech
Gilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure
Fierce Biotech
📢 Published on 📅 April 21, 2026 🕒 07:00
Arcus reports another TIGIT failure as Gilead pulls back from partnership - FirstWord Pharma
Arcus reports another TIGIT failure as Gilead pulls back from partnership
FirstWord Pharma
📢 Published on 📅 April 20, 2026 🕒 07:00
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors - Yahoo Finance
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors
Yahoo Finance
📢 Published on 📅 April 20, 2026 🕒 07:00
AHF Slams Gilead for Role in Florida AIDS Drug Crisis - AIDS Healthcare Foundation
AHF Slams Gilead for Role in Florida AIDS Drug Crisis
AIDS Healthcare Foundation
📢 Published on 📅 April 10, 2026 🕒 07:00
Gilead pays Kymera $45M to glue preclinical protein degrader onto burgeoning oncology pipeline - Fierce Biotech
Gilead pays Kymera $45M to glue preclinical protein degrader onto burgeoning oncology pipeline
Fierce Biotech
📢 Published on 📅 April 9, 2026 🕒 07:00
Commentary: This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people - Los Angeles Times
Los Angeles Times
📢 Published on 📅 April 9, 2026 🕒 07:00
Gilead's Commitment to Bridging the Unmet HIV Treatment Gap - Gilead Sciences
Gilead's Commitment to Bridging the Unmet HIV Treatment Gap
Gilead Sciences
📢 Published on 📅 April 8, 2026 🕒 17:59
With 3 acquisitions to digest, Gilead shifts focus from M&A to pipeline that has 'never been stronger' - Fierce Biotech
Fierce Biotech
📢 Published on 📅 April 8, 2026 🕒 07:00
Gilead Less M&A Happy Now but Door Still Open for ‘Compelling’ Opportunities - BioSpace
Gilead Less M&A Happy Now but Door Still Open for ‘Compelling’ Opportunities
BioSpace
📢 Published on 📅 April 8, 2026 🕒 07:00
'The Testaments' on Hulu heads back to Gilead picking up years after 'The Handmaid's Tale' - ABC7 Eyewitness News
'The Testaments' on Hulu heads back to Gilead picking up years after 'The Handmaid's Tale'
ABC7 Eyewitness News
📢 Published on 📅 April 8, 2026 🕒 07:00
With 3 quick buyouts, Gilead leans into its latest transformation - BioPharma Dive
With 3 quick buyouts, Gilead leans into its latest transformation
BioPharma Dive
📢 Published on 📅 April 8, 2026 🕒 07:00
Gilead continues M&A surge with $3.1B deal for ADC specialist Tubulis - BioPharma Dive
Gilead continues M&A surge with $3.1B deal for ADC specialist Tubulis
BioPharma Dive
📢 Published on 📅 April 7, 2026 🕒 07:00
Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis - BioSpace
Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis
BioSpace
📢 Published on 📅 April 7, 2026 🕒 07:00
Gilead pays $3.1B upfront for Tubulis to bolster oncology ADC pipeline - Fierce Biotech
Gilead pays $3.1B upfront for Tubulis to bolster oncology ADC pipeline
Fierce Biotech
📢 Published on 📅 April 7, 2026 🕒 07:00
Fierce Biotech: Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact - European AIDS Treatment Group
Fierce Biotech: Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact
European AIDS Treatment Group
📢 Published on 📅 April 3, 2026 🕒 19:43
Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact - Fierce Biotech
Gilead cancels midstage HIV trial as FDA’s clinical hold remains intact
Fierce Biotech
📢 Published on 📅 April 1, 2026 🕒 07:00
Open letter to Gilead: Prevention should not be a privilege - Doctors Without Borders
Open letter to Gilead: Prevention should not be a privilege
Doctors Without Borders
📢 Published on 📅 March 30, 2026 🕒 17:22
Gilead refuses to sell groundbreaking HIV prevention drug to MSF - Doctors Without Borders
Gilead refuses to sell groundbreaking HIV prevention drug to MSF
Doctors Without Borders
📢 Published on 📅 March 30, 2026 🕒 13:47
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos - BioSpace
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos
BioSpace
📢 Published on 📅 March 24, 2026 🕒 07:00
Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases - BioPharma Dive
Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases
BioPharma Dive
📢 Published on 📅 March 24, 2026 🕒 07:00
Gilead turns down chance to build on Assembly's phase 1-stage HBV antiviral - Fierce Biotech
Gilead turns down chance to build on Assembly's phase 1-stage HBV antiviral
Fierce Biotech
📢 Published on 📅 March 20, 2026 🕒 07:00
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition - BioSpace
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition
BioSpace
📢 Published on 📅 February 23, 2026 🕒 08:00
Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion - Reuters
Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion
Reuters
📢 Published on 📅 February 23, 2026 🕒 08:00
Latest news from Gilead related to "United States" | Latest News from the United States, United Kingdom & India, local, breaking news
Welcome to news.free-list.org, your online destination for the latest news and breaking stories from the United States, the United Kingdom, and India. Stay informed with real-time updates gathered from trusted sources, newspapers, and online news websites worldwide.
Explore a wide range of news categories including politics, business, technology, health, education, entertainment, and sports. Our platform uses RSS feeds to continuously deliver fresh and up-to-date content, helping you follow global events as they happen.
Whether you are looking for US news, UK headlines, or the latest developments in India, you can easily browse and discover trending topics and important stories in one place. The content is automatically updated to reflect current events and breaking news.
news.free-list.org acts as a modern news aggregator, offering a streamlined way to access news articles from multiple sources without having to visit each site individually. Stay connected to what matters most with fast, reliable, and organized news coverage.
Discover top stories, trending news, and global updates every day. Follow the latest headlines and stay informed about major events across the United States, the United Kingdom, and India with ease.
FreeList.gr: Free Classified Ads for everything in Greece and Cyprus